-
-
-
-
-
-
-
Longeveron presents MRI data on stem cell therapy for Alzheimer's
-
-
-
-
-
-
-
Longeveron (LGVN) Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel in Alzheimer’s Disease
-
-
-
-
-
-
-
Longeveron (LGVN) Announces 2.24M Share Offering at $4.025/sh
-
-
-
-
-
461,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

